tradingkey.logo

Xtant Medical Holdings Inc

XTNT
0.770USD
0.000
交易中 美東報價延遲15分鐘
107.80M總市值
59.51本益比TTM

Xtant Medical Holdings Inc

0.770
0.000

關於 Xtant Medical Holdings Inc 公司

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Inc簡介

公司代碼XTNT
公司名稱Xtant Medical Holdings Inc
上市日期Jun 30, 2010
CEOBrowne (Sean E)
員工數量217
證券類型Ordinary Share
年結日Jun 30
公司地址664 Cruiser Lane
城市BELGRADE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編59714
電話14063880480
網址https://xtantmedical.com/
公司代碼XTNT
上市日期Jun 30, 2010
CEOBrowne (Sean E)

Xtant Medical Holdings Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.52M
+7.95%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
1.07M
+41.87%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
591.99K
-2.79%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
575.01K
+84.46%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.52M
+7.95%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
1.07M
+41.87%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
591.99K
-2.79%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
575.01K
+84.46%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Orthobiologics
19.37M
54.70%
Spinal implant
11.07M
31.25%
License revenue
4.97M
14.05%
地區USD
名稱
營收
佔比
United States
32.13M
90.74%
Rest of World
3.28M
9.26%
業務
地區
業務USD
名稱
營收
佔比
Orthobiologics
19.37M
54.70%
Spinal implant
11.07M
31.25%
License revenue
4.97M
14.05%

股東統計

更新時間: 11月22日 週六
更新時間: 11月22日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
48.85%
Lytton (Laurence W)
6.76%
Vizirgianakis (Stavros G)
5.37%
AWM Investment Company, Inc.
4.71%
The Vanguard Group, Inc.
1.68%
其他
32.63%
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
48.85%
Lytton (Laurence W)
6.76%
Vizirgianakis (Stavros G)
5.37%
AWM Investment Company, Inc.
4.71%
The Vanguard Group, Inc.
1.68%
其他
32.63%
股東類型
持股股東
佔比
Hedge Fund
49.59%
Individual Investor
16.56%
Investment Advisor/Hedge Fund
5.20%
Investment Advisor
2.37%
Research Firm
0.04%
其他
26.23%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
58
80.07M
57.19%
-75.11M
2025Q2
66
93.42M
67.06%
-16.04M
2025Q1
66
107.33M
77.15%
-2.25M
2024Q4
65
107.45M
77.30%
-1.32M
2024Q3
60
109.08M
78.63%
+8.43M
2024Q2
61
99.68M
76.50%
-1.69M
2024Q1
63
100.56M
77.45%
+777.79K
2023Q4
59
100.17M
77.23%
+1.05M
2023Q3
55
100.31M
77.56%
+9.94M
2023Q2
49
90.55M
83.28%
+1.27M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Nantahala Capital Management, LLC
68.39M
48.85%
--
--
Aug 01, 2025
Lytton (Laurence W)
9.46M
6.76%
+9.46M
--
Apr 15, 2025
Vizirgianakis (Stavros G)
6.96M
4.97%
+748.65K
+12.05%
Sep 09, 2025
AWM Investment Company, Inc.
6.60M
4.71%
+6.60M
--
Jun 30, 2025
The Vanguard Group, Inc.
2.25M
1.61%
--
--
Jun 30, 2025
Browne (Sean E.)
1.54M
1.1%
+43.55K
+2.90%
Sep 09, 2025
Beeson (Jonn R.)
1.37M
0.98%
+162.16K
+13.37%
Sep 09, 2025
Bakewell (John K)
755.89K
0.54%
+162.16K
+27.31%
Sep 09, 2025
Renaissance Technologies LLC
650.71K
0.46%
-60.50K
-8.51%
Jun 30, 2025
Neils (Scott C)
311.72K
0.22%
+111.54K
+55.72%
Sep 09, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Xtant Medical Holdings Inc的前五大股東是誰?

Xtant Medical Holdings Inc的前五大股東如下:
Nantahala Capital Management, LLC
持有股份:68.39M
佔總股份比例:48.85%。
Lytton (Laurence W)
持有股份:9.46M
佔總股份比例:6.76%。
Vizirgianakis (Stavros G)
持有股份:6.96M
佔總股份比例:4.97%。
AWM Investment Company, Inc.
持有股份:6.60M
佔總股份比例:4.71%。
The Vanguard Group, Inc.
持有股份:2.25M
佔總股份比例:1.61%。

Xtant Medical Holdings Inc的前三大股東類型是什麼?

Xtant Medical Holdings Inc 的前三大股東類型分別是:
Nantahala Capital Management, LLC
Lytton (Laurence W)
Vizirgianakis (Stavros G)

有多少機構持有Xtant Medical Holdings Inc(XTNT)的股份?

截至2025Q3,共有58家機構持有Xtant Medical Holdings Inc的股份,合計持有的股份價值約為80.07M,占公司總股份的57.19% 。與2025Q2相比,機構持股有所增加,增幅為-9.87%。

哪個業務部門對Xtant Medical Holdings Inc的收入貢獻最大?

在FY2025Q2,Orthobiologics業務部門對Xtant Medical Holdings Inc的收入貢獻最大,創收19.37M,占總收入的54.70% 。
KeyAI